1 minute
TLT has advised a Glasgow-based diagnostics company that has pioneered the early detection and identification of cancer on a multimillion-pound investment. The funding will facilitate the business’ growth and expand its commercial presence in the US.
3 minutes
Dxcover — a Glasgow-based company developing a blood test that can detect cancer at an early stage — has raised £9.7 million through a Series A investment round and grant funding. The £7.5m funding round was led by existing investors Eos Advisory LLP, Mercia Asset M
SUBSCRIBE
